4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-016097
EVP, Growth Markets Commercial sold 512 shares at $16.88 ($8,645)
- EVP, Growth Markets Commercial acquired 1,399 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Nazzi Gianfranco · EVP, Growth Markets Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-03 | Exercise or conversion : show line 1 in the form | +1,399 | 8,404.36 | D | ||
| 2019-03-04 | Sale : show line 2 in the form | −512 | $16.88 | $8,645 | 7,892.36 | D |
| Open-market sales · 512 sh · avg $16.88 · $8,645 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-03-03 | Exercise or conversion : show line 3 in the form Restricted Share Units | −1,399 | 2,799 | D |
Loading xslF345X03/doc4.xml…